Short answer · Medically reviewed summary · Last updated: 2026-04-07
Small Fiber Neuropathy (SFN) does not have a unique, dedicated ICD-10 code; it is typically classified under G63 (polyneuropathy in diseases classified elsewhere) or G62.89 (other specified polyneuropathies). Similarly, in the ICD-9 system, Small Fiber Neuropathy was commonly coded as 357.9 (unspecified inflammatory and toxic neuropathy) or 357.7 (neuropathy in diabetes), depending on the underlying etiology. Why is there no specific ICD code for Small Fiber Neuropathy? In medical coding, Small Fiber Neuropathy is often considered a clinical manifestation of an underlying condition rather than a standalone disease entity in the legacy coding systems.
2 people with Small Fiber Neuropathy have shared their first-person experience on this question at DiseaseMaps.
Small Fiber Neuropathy (SFN) does not have a unique, dedicated ICD-10 code; it is typically classified under G63 (polyneuropathy in diseases classified elsewhere) or G62.89 (other specified polyneuropathies). Similarly, in the ICD-9 system, Small Fiber Neuropathy was commonly coded as 357.9 (unspecified inflammatory and toxic neuropathy) or 357.7 (neuropathy in diabetes), depending on the underlying etiology.
In medical coding, Small Fiber Neuropathy is often considered a clinical manifestation of an underlying condition rather than a standalone disease entity in the legacy coding systems. Because Small Fiber Neuropathy involves damage to the small, unmyelinated nerve fibers (A-delta and C-fibers) that regulate pain, temperature, and autonomic function, it is frequently secondary to systemic diseases like diabetes, Sjögren’s syndrome, or amyloidosis. Consequently, clinicians often use the ICD-10 code for the primary disease while adding a secondary code for the neuropathic symptoms, which can make tracking the exact prevalence of idiopathic Small Fiber Neuropathy challenging for researchers.
Receiving a diagnosis of Small Fiber Neuropathy can be a long and difficult journey, as standard nerve conduction studies (NCS) and electromyography (EMG) often return normal results because these tests only measure large, myelinated nerve fibers. For our community of 209 members on DiseaseMaps.org, the realization that Small Fiber Neuropathy affects the small nerve endings in the skin often marks the beginning of targeted testing. Physicians typically rely on specific diagnostic tools to confirm the condition:
Small Fiber Neuropathy can be both. While many cases are "idiopathic" (unknown cause), genetic research has identified specific mutations in the SCN9A, SCN10A, and SCN11A genes that can cause hereditary forms of Small Fiber Neuropathy. It is essential for patients to consult with a clinical geneticist if there is a family history of neuropathic pain or autonomic dysfunction. For others, the disease is acquired through autoimmune processes, metabolic disorders, or exposure to neurotoxic substances.
Managing Small Fiber Neuropathy requires a multidisciplinary approach, as patients often face not only physical pain but also significant emotional distress due to the "invisible" nature of the condition. Treatment usually focuses on symptom management, including neuropathic pain medications (such as gabapentinoids or SNRIs), topical treatments (lidocaine or capsaicin), and, in cases of autoimmune-mediated Small Fiber Neuropathy, intravenous immunoglobulin (IVIG) or corticosteroids.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.